PT Royal Prima Tbk (ISX:PRIM) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PRIM PT Royal Prima Tbk ISX:PRIM
74 GF Score
Price Rp98.00
GF Value Rp81.59
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is PT Royal Prima Tbk FFO?

FFO (Funds from operations) only applies to REITs.

ISX:PRIM
74GF Score
PT Royal Prima Tbk ISX:PRIM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?

Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued. The current stock price of Rp98.00 is trading 20.1% above its estimated GF Value™ of Rp81.59. GuruFocus considers PT Royal Prima Tbk to be Modestly Overvalued.

Key valuation signals for ISX:PRIM:

  • FFO:
  • GF Value™: Rp81.59 vs. price of Rp98.00 (20.1% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Royal Prima Tbk Business Description

Address Jalan. Ayahanda No. 68A, Sumatera Utara, Medan, IDN, 20118
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
74GF Score

Get the complete analysis for ISX:PRIM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp98.00
Price
Rp81.59
GF Value